Groundbreaking trial proves gene therapy can restore hearing
A new gene therapy has helped 10 people aged 1 to 24, born deaf due to OTOF gene mutations, regain their hearing.
The treatment uses a modified virus to deliver a healthy version of the gene, restoring a key protein needed for hearing.
Treatment shows promise
Everyone in the trial saw real progress within a month—on average, hearing improved by over 60% on tests and nearly 80% in daily life.
Younger kids (especially ages 5-8) did especially well; one seven-year-old could hear sounds just three days after treatment.
No serious side effects showed up during follow-ups
No serious side effects showed up during follow-ups, which is promising for those who can't use cochlear implants.
Researchers are excited about using this approach for other types of genetic hearing loss too.
New hope for people with genetic deafness
This breakthrough could mean new hope for people with genetic deafness—and it's just the start.
Researchers believe similar treatments might help even more folks with different kinds of inherited hearing loss down the road.